1. Lommatzsch M, Criée CP, de Jong CCM, Gappa M, Geßner C, Gerstlauer M et al. S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023 - herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 2023;77:461-543
2. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, van Wijk RG et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy 2018;73:765-98
3. Penagos M, Durham SR. Duration of allergen immunotherapy for inhalant allergy. Curr Opin Allergy Clin Immunol 2019;19:594-605
4. Brehler R, Pfaar O, Canonica GW, Devillier P, Demoly P, Scurati S et al. Treatment effect of 300IR 5-grass pollen tablet for pre-coseasonal sublingual immunotherapy of grass pollen-induced allergic rhinoconjunctivitis: clinical impact from the patient perspective. EAACI Congress 2023; Abstract TP-C275
5. Pfaar O, Gerstlauer M, De Blay F, Devillier P, Brehler R, Demoly P et al. Treatment effect of 300IR birch pollen allergen extract sublingual solution in birch pollen-induced allergic rhinoconjunctivitis: clinical impact from the patient perspective. EAACI Congress 2023; Abstract TP-C276